You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

Intl Medication Sys Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INTL MEDICATION SYS, and what generic and branded alternatives to INTL MEDICATION SYS drugs are available?

INTL MEDICATION SYS has six approved drugs.

Summary for Intl Medication Sys
US Patents:0

Drugs and US Patents for Intl Medication Sys

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Intl Medication Sys CALCIUM CHLORIDE 10% calcium chloride INJECTABLE;INJECTION 203477-001 May 9, 2018 AP RX No No   Start Trial   Start Trial
Intl Medication Sys SODIUM BICARBONATE sodium bicarbonate INJECTABLE;INJECTION 203449-001 Sep 19, 2017 AP RX No No   Start Trial   Start Trial
Intl Medication Sys MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 087509-001 Oct 5, 1982 DISCN No No   Start Trial   Start Trial
Intl Medication Sys LORAZEPAM lorazepam INJECTABLE;INJECTION 076150-001 Nov 15, 2004 AP RX No No   Start Trial   Start Trial
Intl Medication Sys EPINEPHRINE epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 211880-001 Apr 24, 2020 AP RX No No   Start Trial   Start Trial
Intl Medication Sys AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 021594-001 Feb 4, 2004 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.